This morning, Cellectar Biosciences announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to CLR 131 for the treatment of neuroblastoma. CLR 131 is the company’s lead Phospholipid Drug Conjugate …
Cancer Center News
New Treatment for Lymphoma
Wisconsin Public Radio’s The Larry Meiller Show talks to Dr. Christian Capitini about a new treatment for lymphoma that uses the patient’s own T-cells. Listen to the recording here.
Dr. Al-Niaimi Discusses Cytoreductive Surgery in Ovarian Cancer
Ahmed N. Al-Niaimi, MD, assistant professor of obstetrics and gynecology, University of Wisconsin School of Medicine and Public Health, discusses cytoreductive surgery in ovarian cancer. Reaching optimal cytoreduction is complicated, so collaboration is key reaching …
UW Carbone Cancer Center Receives ‘Outstanding’ Grade on Renewal
Every five years, the UW Carbone Cancer Center receives a thorough check-up from the nation’s top cancer researchers. Leaders recently learned that it passed its review with flying colors and will retain its designation as Wisconsin’s only National Cancer …
Driving the CAR-T toward better cancer treatments
Leukemia is one of the most common cancers of childhood. So, as childhood cancer awareness month comes to a close on this almost final day of September, we wanted to take a moment to help explain a groundbreaking …
University of Wisconsin picked as a site to provide promising and expensive cancer drug
The University of Wisconsin-Madison’s American Family Children’s Hospital will be one of 20 sites to offer one of the most promising and expensive new cancer drugs, one that will come with what amounts to a …